<- Go Home

Illumina, Inc.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally.

Market Cap

$19.5B

Volume

2.1M

Cash and Equivalents

$920.0M

EBITDA

$635.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$2.9B

Profit Margin

66.34%

52 Week High

$174.52

52 Week Low

$89.00

Dividend

N/A

Price / Book Value

13.54

Price / Earnings

-6.37

Price / Tangible Book Value

246.11

Enterprise Value

$21.4B

Enterprise Value / EBITDA

28.04

Operating Income

$205.0M

Return on Equity

-76.19%

Return on Assets

1.44

Cash and Short Term Investments

$994.0M

Debt

$2.9B

Equity

$1.4B

Revenue

$4.4B

Unlevered FCF

$907.1M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches